Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
29,347,880
-
Share change
-
-477,460
-
Total reported value
-
$193,099,929
-
Put/Call ratio
-
70%
-
Price per share
-
$6.58
-
Number of holders
-
71
-
Value change
-
-$3,061,002
-
Number of buys
-
24
-
Number of sells
-
36
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2019
As of 30 Jun 2019,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,347,880 shares.
The largest 10 holders included
NEA Management Company, LLC, Consonance Capital Management LP, ORBIMED ADVISORS LLC, Polar Capital LLP, FMR LLC, Vivo Capital, LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, ACUTA CAPITAL PARTNERS, LLC, and BlackRock Inc..
This page lists
71
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.